Flagship Wealth Advisors’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
Other funds holding AVXL
Flagship Wealth Advisors's AVXL Position: Q3 2026 in Review
Flagship Wealth Advisors opened a new position in Anavex Life Sciences (AVXL) in Q3 2026: 100 shares worth $202. The stake represents ﹤0.01% of the portfolio and ranks #459 among its holdings.
162 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.
- Flagship Wealth Advisors held 100 shares of Anavex Life Sciences worth $202 as of Q3 2026.
- Anavex Life Sciences was a new Flagship Wealth Advisors position in Q3 2026.
- Anavex Life Sciences made up ﹤0.01% of Flagship Wealth Advisors's portfolio in Q3 2026, its #459 holding.
- 162 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.
Based on Flagship Wealth Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.